Results 181 to 190 of about 67,974,619 (226)

Describing flares: a mixed methods study comparing patient and clinician perspectives in systemic lupus erythematosus and other rheumatic diseases. [PDF]

Rheumatology (Oxford)
Piper MA, Tunks A, Bourgeois JA, Calderwood L, D'Cruz D, Bortoluzzi A, Arunasalam A, Tayabali S, Taylor S, Saha P, Yates M, Hamilton-Conaty P, Kaul A, Sloan M.   +13 more
europepmc   +1 more source

Serum total cholesterol, calcium, and IgG as discriminatory markers of lupus nephritis in children with systemic lupus erythematosus. [PDF]

Front Pediatr
Jiang J, He Q, Gao H, Li W, Zheng H.
europepmc   +1 more source

TNFSF4/OX40L and IKZF1/IKAROS Genetic Variant Associations with Egyptian Juvenile Systemic Lupus Erythematosus (JSLE). [PDF]

Biology (Basel)
Attia ZR, Amshawee AM, Hasan AF, Hussein DT, Abd El Azeem RA, Zedan MM, Mutawi TM, El-Beltagy NS, El Basuni MA.   +8 more
europepmc   +1 more source

Proceedings of the 33rd European Paediatric Rheumatology Congress. [PDF]

Pediatr Rheumatol Online J
europepmc   +1 more source

Cardiovascular Morbidity in Juvenile-Onset Systemic Lupus Erythematosus

openaire   +1 more source

Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus: Data From the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort Study [PDF]

Lupus, 2021
Introduction Juvenile-onset systemic lupus erythematosus (JSLE) is a rare autoimmune/inflammatory disease with significant morbidity and mortality. Neuropsychiatric (NP) involvement is a severe complication, encompassing a heterogeneous range of neurological and psychiatric manifestations.
Athimalaipet V Ramanan, Teresa Giani, Christian M Hedrich   +2 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Outcome in juvenile onset systemic lupus erythematosus

Current Opinion in Rheumatology, 2005
Over the past 2 decades, there has been a marked improvement in survival among patients with juvenile-onset systemic lupus erythematosus. As a result of the increased life expectancy, children and adolescents with systemic lupus erythematosus are now faced with considerable morbidity resulting from sequelae of disease activity, side effects of ...
RAVELLI, ANGELO, RUPERTO N, MARTINI, ALBERTO   +2 more
openaire   +3 more sources

Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus

Pediatric Drugs, 2002
Systemic lupus erythematosus (SLE) is an inflammatory chronic disease characterized by the presence of activated helper T-cells that induce a B-cell response, resulting in the secretion of pathogenic autoantibodies and the formation of immune complexes.
Luis, Carreño, Francisco Javier, López-Longo, Carlos Manuel, González, Indalecio, Monteagudo   +3 more
openaire   +2 more sources

Comparison of juvenile and adult onset systemic lupus erythematosus

British Journal of Hospital Medicine, 2012
Systemic lupus erythematosus is a multisystem autoimmune disease of unknown aetiology, described as juvenile systemic lupus erythematosus if the onset is before 16–18 years of age. This review outlines current understanding of juvenile systemic lupus erythematosus and differences between this and adult onset disease.
Tanya, Baqai, Yiannis, Ioannou
openaire   +2 more sources